Skip to content

Research on gut biomarkers through study food in subjects who are aware they are prone to catching colds

Research on gut biomarkers through study food in subjects who are aware they are prone to catching colds - Research on gut biomarkers through study food in subjects who are aware they are prone to catching colds

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000059573
Enrollment
100
Registered
2025-11-04
Start date
2025-11-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Consecutive intake of study food one tablet once daily for 12 weeks Consecutive intake of placebo one tablet once daily for 12 weeks

Sponsors

EP Mediate Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Healthy males and females from 20 to 64 years of age (2) Subjects who are aware they are prone to catching colds (3) Subjects who fully understand the purpose and content of the study and voluntarily agree to participate in the study

Exclusion criteria

Exclusion criteria: (1) Subjects who have a disease requiring constant medication, with a disease under treatment, or with a history of a serious disease requiring medication therapy (2) Subjects suffering from gastrointestinal disorders that affect digestion absorption, defecation or who have a history of previous illnesses or surgeries (3) Subjects with chronic and severe constipation or tendency toward diarrhea/loose stools, or who exhibiting distinct digestive symptoms from specific foods like lactose intolerance or gluten-related disorders (4) Subjects with pre-existing conditions that require diet therapy under the guidance of a doctor (5) Subjects who have atopic dermatitis, bronchial asthma, and chronic bronchitis (6) Subjects who may require medication or treatment for hay fever or allergic rhinitis, or may cause difficulties in daily life (7) Subjects who are taking medicines, health foods that may affect immune function or bowel movements at least 3 times a week, or plan to take (8) Subjects who have reported allergies to food or medicines, or individuals at risk of developing allergies (9) Subjects who habitually consume foods rich lactic acid bacteria, lactic acid bacteria preparations, or foods rich acetic acid bacteria at least 3 times per week (10) Subjects who vaccinated within 4 weeks, or hope for vaccination (11) Subjects planning to travel abroad (12) Subjects determined to have excessive drinking or smoking habits (13) Subjects who are becoming pregnant and lactating or intend to become pregnant (14) Subjects engaged in shift work involving day and night rotations or physically demanding labor such as heavy lifting (15) Subjects who habitually engage in strenuous exercise such as marathon running (16) Subjects who participated in another clinical trial within 1 month, or plan to participate (17) Subjects whose screening values show significant deviation from reference range (18) Subjects who are judged as unsuitable for the study by the investigator

Design outcomes

Primary

MeasureTime frame
fecal s-IgA

Secondary

MeasureTime frame
bowel movement record (number, stool characteristics (form, color, odor, feeling after defecation))

Countries

Japan

Contacts

Public ContactKeiji Yamamoto

EP Mediate Co., Ltd. Development Department Trial Planning Section

yamamoto.keiji799@eps.co.jp070-3023-8214

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026